Aureate Tradde IPO Final Day: GMP ₹10 (+₹3)
Welcome back, investors! Today marks the grand finale for the Aureate Tradde SME IPO on the BSE, and it’s been quite a journey. As we close the books on Day 5, the subscription numbers are still a bit of a puzzle, but the Grey Market Premium (GMP) is certainly painting a brighter picture. Let’s dive into what it all means for you.
| Date | GMP | Est. Listing |
|---|---|---|
| 02 Jun | +₹12 | ₹82 |
| 01 Jun | +₹10 | ₹80 |
| 30 May | +₹7 | ₹77 |
| 29 May | ₹0 | ₹70 |
| 28 May | ₹0 | ₹70 |
Subscription Status
As of the closing bell on Day 5, Aureate Tradde’s IPO has seen 0x subscription across all categories – Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). This might seem alarming at first glance, especially for a company looking to make its mark. However, it’s crucial to remember that SME IPOs often see a surge of interest towards the very end, particularly on the last day. Investors, especially retail, tend to wait until the eleventh hour to make their decisions, often influenced by the final GMP and market sentiment. The lack of early subscription doesn’t necessarily spell doom; it could simply indicate cautious optimism or a wait-and-watch approach from potential applicants. For QIBs and NIIs, this waiting game can also be strategic, allowing them to gauge the overall demand before committing significant capital.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 2.42x | |
| NII / HNI | 0.00x | |
| QIB | 0.00x | |
| Total | 1.49x |
| Date | Retail | NII | QIB | Total |
|---|---|---|---|---|
| 02 Jun | 2.42x | 0.00x | 0.00x | 1.49x |
| 01 Jun | 1.36x | 0.00x | 0.00x | 0.81x |
| 29 May | 0.26x | 0.00x | 0.00x | 0.16x |
GMP Update
Now, for the part that’s really turning heads: the Grey Market Premium (GMP). Yesterday, Aureate Tradde’s GMP stood at a respectable ₹7 per share. Today, it’s jumped by ₹3 to a strong ₹10! This is encouraging news. A rising GMP on the closing day often signals increasing investor confidence and anticipation for a strong listing. At an issue price of ₹70, a GMP of ₹10 suggests an expected listing price of around ₹80. This implies a potential listing gain of approximately 14.3%. This upward trend in GMP is a positive indicator, suggesting that the market is willing to pay a premium for Aureate Tradde’s shares, even if the subscription numbers are yet to fully reflect that enthusiasm.
Should You Apply?
This is the million-dollar question, isn’t it? On one hand, the subscription numbers are flat, which can be a red flag for some. You’d typically want to see strong demand building throughout the IPO period. However, the significant uptick in GMP is a powerful counterpoint. It suggests that while the formal subscription channels might be slow to fill, behind the scenes, there’s a growing buzz and willingness to pay more than the issue price. The lot size is 2000 shares, so even a ₹10 GMP translates to a ₹20,000 potential profit per lot. Remember, the SEBI advisor’s disclaimer is always in play: IPOs, especially SME ones, carry inherent risks. The final decision rests on your risk appetite. If you’re comfortable with the potential for a strong listing gain as indicated by the GMP, and you believe in the company’s fundamentals (which you should always research separately), then the current GMP might make it an attractive proposition. Conversely, if you prefer to see concrete subscription numbers before committing, you might choose to sit this one out. The market is dynamic, and the next few hours could bring further surprises. For a deeper dive into all the details, you can always View Full Aureate Tradde IPO Details.